Ali Mostajelean
Neurology with Special Qualifications in Child Neurology · Oakland, CANPI 1174848238
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,184 of the $7,030 with a category attached, or 88.0%. 17 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 27.8% of the total. Reporting peaked in 2024 at $1,653 and has fallen 59.3% since, to $672 in 2025.
Across 199 payments — averaging $35.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$2K
- UCB, Inc.$935
- Vertex$847
- Neurelis, Inc.$725
- Greenwich Biosciences, Inc.$639
- SK Life Science, Inc.$541
- plus $1K from 11 others
Across 3 payments — averaging $53,705 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$161K
What the payments were for
- Consulting fees$84712%
- Food & beverage$6,18488%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 84 | $1,953 |
| UCB, Inc. | 15 | $935 |
| Vertex | 2 | $847 |
| Neurelis, Inc. | 20 | $725 |
| Greenwich Biosciences, Inc. | 25 | $639 |
| SK Life Science, Inc. | 18 | $541 |
| Neuropace, Inc. | 7 | $417 |
| Immedica Pharma US, Inc. | 7 | $285 |
| Zogenix Inc. | 10 | $154 |
| Novartis | 1 | $135 |
| Sunovion Pharmaceuticals Inc. | 1 | $125 |
| Biocodex, Inc. | 2 | $121 |
| Mallinckrodt Enterprises LLC | 2 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| Aquestive Therapeutics, Inc. | 1 | $27 |
| Nobelpharma America, LLC | 1 | $20 |
| Biomarin Pharmaceutical Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epidiolex$537
- VALTOCO$244
- RNS Neurostimulator Kit$150
- AFINITOR$135
- APTIOM$125
How this compares
$7,030 in reported general payments places this provider in the 75th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Oakland
- Allen BottOakland$372K
- Jennifer Martelle TuOakland$8K
- Michael ChezSacramento$374K
- Joseph SullivanSan Francisco$240K
- Ann SegerenStanford$172K
- Rajsekar RajaramanLos Angeles$134K
- Deborah HolderLos Angeles$130K
- Akash VirupakshaiahSan Francisco$94K
- Brittany PassiakSan Diego$90K
- Kevin ShapiroMadera$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.